NeuroPace, Inc.

NPCE· NASDAQ· Health Care· Health Care Equipment & Services

$14.15+0.35%

2026-09-17

Financials

Valuation Metrics

NeuroPace, Inc.'s Market Cap is $482M. At end of 2025 it was $505M. Ranked #2809 of 3,121 in US market (top 90%), #1233 of 1,463 on NASDAQ (top 84%), #171 of 205 in Health Care Equipment & Services (top 83%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$482M	US#2,809/3,121 Sec#171/205
Revenue	$99M	US#2,707/3,121 Sec#185/205
Net Income	$-19M	US—/3,121 Sec—/205
Total Assets	$97M	US#3,065/3,121 Sec#201/205
Net Assets	$12M	US#2,910/3,121 Sec#191/205
Value
P/B	40.60x	US#2,878/3,121 Sec#190/205
P/S	4.88x	US#2,279/3,121 Sec#151/205
FCF Yield	-2.41%	US—/3,121 Sec—/205
Profitability
ROE	-160.85%	US#2,830/3,121 Sec#186/205
ROA	-19.71%	US#2,792/3,121 Sec#176/205
Op. Margin	-15.26%	US#2,581/3,121 Sec#163/205
Revenue Growth	11.59%	US#1,136/3,121 Sec#77/205
Financial Health
Debt Ratio	716.22%	US#2,542/3,121 Sec#187/205
Total Debt	$70M	US#2,538/3,121 Sec#149/205
FCF	$-12M	US#2,383/3,121 Sec#154/205
Cash	$13M	US#2,946/3,121 Sec#198/205
Current Ratio	4.94x	US#480/3,121 Sec#39/205
Performance
1Y Return	43.07%	US#664/3,121 Sec#55/205
1M Return	-2.21%	US#1,248/3,121 Sec#112/205
From 52W High	-27.81%	US#1,942/3,121 Sec#135/205
1Y MDD	-33.18%	US#1,645/3,121 Sec#84/205
Trading
Volume	106,085 shares	US#2,891/3,121 Sec#196/205
Trading Value	$2M	US#2,960/3,121 Sec#188/205
Per Share
EPS	$-0.56	US—/3,121 Sec—/205
BPS	$0.35	US#2,779/3,121 Sec#192/205